Insys Therapeutics Stock Predictions

Buy INSY

*Your capital is at risk

$0.255

+0 (+0%)

At Close: Sep 17, 2019

Currently predicting for Fri, 5 Jun 2026

INSY Prediction Chart

INSY Predictions History

Latest community submissions for INSY.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Abdu Pro @Abdu.1501	Nov 17, 2016	$13.74 +1.85%	$13.49	X	98.10%	0
JS Pro	Nov 17, 2016	$13.21 -2.08%	$13.49	X	97.90%	0
JS Pro	Nov 10, 2016	$13.96 -0.64%	$14.05	X	99.40%	3
Steve.Sullivan.925	Nov 10, 2016	$14.65 +4.27%	$14.05	X	95.70%	0
paul.shaffer.1417	Nov 3, 2016	$15.95 +59.18%	$10.02	X	40.80%	0
JS Pro	Aug 10, 2016	$18.90 +0.69%	$18.77	X	99.30%	3

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for INSY with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT INSYS THERAPEUTICS

Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by